WASHINGTON (Reuters) - Jerry Mayfield figures he has had two lucky breaks. <p>The first was after he was diagnosed with leukemia, and found a new drug called Gleevec, making headlines because of its astonishing effects in some cancer patients. <p>The second was after Gleevec failed him, and Mayfield enrolled in an experimental trial for the next-generation Gleevec, designed to help people precisely like himself. And he wants people to know about it. <p>His Internet diary is read by thousands of patients with chronic myeloid leukemia, which affects about 4,400 Americans a year, 10,000 around the world.<p>***There is much wrong with these first four paragraphs, but I'll focus on this: We're meant to understand that 44% of all people with this disease live in the United States? On the off chance that this is true, it certainly warrants an explainer.***<p>[ July 18, 2004: Message edited by: Matthew Grieco ]</p>
|